Sabby Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Sabby Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,003	Closed	-$13.7M	–	230
2017 Q4	$13.7M	Buy	+3,003	New	+$150K	1.25%	16
2017 Q1	–	Sell	-103	Closed	-$194K	–	359
2016 Q4	$194K	Hold	103	–	–	0.01%	241
2016 Q3	$309K	Sell	103 -137	-57%	-$4.26K	0.01%	254
2016 Q2	$923K	Buy	240 +173	+258%	+$7.18K	0.05%	169
2016 Q1	$255K	Buy	+67	New	+$2.33K	0.01%	251

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Sabby Management's JUNO Position: Q3 2015 in Review

Sabby Management sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2015, closing a stake of 11,333 shares — an estimated $604K sold.

Sabby Management first reported a position in JUNO in Q2 2015 and held it in 1 quarter. The position peaked at $604K in Q2 2015. 132 funds tracked by Wall St. Rank hold JUNO as of Q3 2015.

Sabby Management reported no remaining Juno Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Sabby Management sold 11,333 Juno Therapeutics, Inc. shares in Q3 2015, an estimated $604K.
Sabby Management first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 1 quarter.
Sabby Management's Juno Therapeutics, Inc. position peaked at $604K in Q2 2015.
132 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2015.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.